Phreesia (PHR) Insider Lisa Egbuonu-Davis Buys $185K of Stock

Insider Buying and Selling at Phreesia, Inc.

On June 25, 2026, Lisa Egbuonu-Davis bought 2,546 shares of Phreesia, Inc. (NYSE: PHR) at an average price of $9.53 each, totaling about $24,263. This transaction comes just one day after a wave of insider buying at the company, which reflects growing confidence among its leadership.

A Surge in Insider Activity

Egbuonu-Davis's purchase follows a notable day on June 24, when five other insiders made significant buys. Jon Kessler, Gillian Munson, Ramin Sayar, Smith Mark Douglas, and Lainie Goldstein each acquired 19,290 shares at $9.59, resulting in a total value of about $184,991 for each transaction. This level of insider buying is relatively large compared to typical insider activity and suggests strong belief in the company's future prospects.

Analysts Set New Price Targets

Analysts have recently weighed in on Phreesia's stock, maintaining a varied outlook. On October 12, 2026, Barclays maintained its Equal-Weight rating with a price target of $11.00, while DA Davidson continues to rate the stock as a Buy with a target of $13.00. Meanwhile, Raymond James downgraded its rating to Market Perform on September 8, 2026. The consensus reflects a mix of cautious optimism and ongoing support for the company.

How Phreesia, Inc. Stock Has Traded

Phreesia shares traded at about $10.07 on the day of Egbuonu-Davis's purchase, which is above its 52-week low of $7.77 but well below its high of $25.00. The stock's current position near the 50-day moving average of $11.15 suggests it has faced some fluctuations recently, making the insider buying more noteworthy.

What Phreesia, Inc. Does

Phreesia, Inc. provides a software platform for healthcare organizations in the U.S. and Canada. Its offerings include appointment management, patient communications, and integrated payment solutions. The recent insider activity indicates confidence in its business model and growth potential in the healthcare technology sector.

What’s Next for Phreesia

Looking ahead, investors will be watching for the company's next earnings report scheduled for December 7, 2026. The recent insider buying, particularly by Egbuonu-Davis and her colleagues, may signal a positive outlook for Phreesia as it prepares for this upcoming milestone. As a reminder, the insider transactions reported reflect past positions and may not indicate current holdings.